Paolo Parini

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Paolo Parini är professor i klinisk kemi och forskar om kardiometabola sjukdomar på molekylär nivå. Han är också koordinator för Cardio Metabolic Unit (CMU) vid KI Campus Flemingsberg.

Artiklar

Article: ATHEROSCLEROSIS. 2024;394:117545

Modification of lipoprotein metabolism and function driving atherogenesis in diabetes

Luciani L; Pedrelli M; Parini P
Article: EPMA JOURNAL. 2024;15(2):149-162

Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position

Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
Article: GENOME BIOLOGY. 2024;25(1):104

Single Cell Atlas: a single-cell multi-omics human cell encyclopedia

Pan L; Parini P; Tremmel R; Loscalzo J; Lauschke V; Maron B; Paci P; Ernberg I; Tan NS; Liao Z; Yin W; Rengarajan S; Li X
Article: EUROPEAN HEART JOURNAL OPEN. 2024;4(2):oeae010

Relation among hypertriglyceridaemia, cardiometabolic disease, and hereditary factors-design and rationale of the Stockholm hyperTRIglyceridaemia REGister study.

Andersson DP; Littmann K; Kindborg G; Eklund D; Sejersen K; Yan J; Eriksson Hogling D; Parini P; Brinck J
Article: EPMA JOURNAL. 2024;15(1):1-23

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation

Golubnitschaja O; Polivka Jr J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Froehlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
Article: FRONTIERS IN PHYSIOLOGY. 2024;15:1371096

The nonvesicular sterol transporter Aster-C plays a minor role in whole body cholesterol balance

Banerjee R; Hohe RC; Cao S; Jung BM; Horak AJ; Ramachandiran I; Massey WJ; Varadharajan V; Zajczenko NI; Burrows AC; Dutta S; Goudarzi M; Mahen K; Carter A; Helsley RN; Gordon SM; Morton RE; Strauch C; Willard B; Gogonea CB; Gogonea V; Pedrelli M; Parini P; Brown JM
Article: SCIENCE ADVANCES. 2023;9(20):eadf2982

Mice with humanized livers reveal the role of hepatocyte clocks in rhythmic behavior

Delbes A-S; Quinones M; Gobet C; Castel J; Denis RGP; Berthelet J; Weger BD; Challet E; Charpagne A; Metairon S; Piccand J; Kraus M; Rohde BH; Bial J; Wilson EM; Vedin L-L; Minniti ME; Pedrelli M; Parini P; Gachon F; Luquet S
Article: REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022;23(5):919-930

Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

Al-Massadi O; Parini P; Ferno J; Luquet S; Quinones M
Article: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):296-307

Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice

Pramfalk C; Ahmed O; Pedrelli M; Minniti ME; Luquet S; Denis RG; Olin M; Hardfeldt J; Vedin L-L; Steffensen KR; Ryden M; Hodson L; Eriksson M; Parini P
Article: JOURNAL OF LIPID RESEARCH. 2022;63(7):100232

Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans

Pavanello C; Ossoli A; Strazzella A; Rise P; Veglia F; Lhomme M; Parini P; Calabresi L
Article: BIOFACTORS. 2022;48(3):707-717

HDL-mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition

Ossoli A; Giorgio E; Cetti F; Ruscica M; Rabacchi C; Tarugi P; Parini P; Pedrelli M; Gomaraschi M
Article: ATHEROSCLEROSIS. 2022;349:175-182

Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period

Wodaje T; Littmann K; Habel H; Bottai M; Back M; Parini P; Brinck J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2022;28(18):2038-2047

Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up

Littmann K; Hagstrom E; Habel H; Bottai M; Eriksson M; Parini P; Brinck J
Article: ATHEROSCLEROSIS. 2021;338:55-63

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgozoglu L
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(18):9969

Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in Pparg-Null Mice

Schiffrin M; Winkler C; Quignodon L; Naldi A; Trotzmuller M; Kofeler H; Henry H; Parini P; Desvergne B; Gilardi F
Article: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. 2021;321(3):G243-G251

Liver X receptor β regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder

Sweed N; Kim H-J; Hultenby K; Barros R; Parini P; Sancisi V; Strandvik B; Gabbi C
Article: SOCIAL SCIENCE & MEDICINE. 2021;282:114145

It takes two to dance the VBHC tango: A multiple case study of the adoption of value-based strategies in Sweden and Brazil

Ramos P; Savage C; Thor J; Atun R; Carlsson KS; Makdisse M; Neto MC; Klajner S; Parini P; Mazzocato P
Article: JOURNAL OF LIPID RESEARCH. 2021;62:100065

Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)

Pedrelli M; Parini P; Kindberg J; Arnemo JM; Bjorkhem I; Aasa U; Westerstahl M; Walentinsson A; Pavanello C; Turri M; Calabresi L; Oorni K; Camejo G; Frobert O; Hurt-Camejo E
Article: JCI INSIGHT. 2020;5(24):140483

Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease

Cansby E; Caputo M; Gao L; Kulkarni NM; Nerstedt A; Stahlman M; Boren J; Porosk R; Soomets U; Pedrelli M; Parini P; Marschall H-U; Nystrom J; Howell BW; Mahlapuu M
Article: HEPATOLOGY. 2020;72(2):656-670

Insights From Liver-Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR-Agonist Pharmacodynamics in Humans

Minniti ME; Pedrelli M; Vedin L-L; Delbes A-S; Denis RGP; Oorni K; Sala C; Pirazzini C; Thiagarajan D; Nurmi HJ; Grompe M; Mills K; Garagnani P; Ellis ECS; Strom SC; Luquet SH; Wilson EM; Bial J; Steffensen KR; Parini P
Article: DIABETES CARE. 2020;43(8):1851-1858

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

Littmann K; Wodaje T; Alvarsson M; Bottai M; Eriksson M; Parini P; Brinck J
Article: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2020;1865(6):158659

Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism

Pramfalk C; Jakobsson T; Verzijl CRC; Minniti ME; Obensa C; Ripamonti F; Olin M; Pedrelli M; Eriksson M; Parini P
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2020;499:110604

Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity

Gnocchi D; Ellis ECS; Johansson H; Eriksson M; Bruscalupi G; Steffensen KR; Parini P
Article: JOURNAL OF CLINICAL LIPIDOLOGY. 2020;14(1):77-87

Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

Taskinen M-R; Bjornson E; Andersson L; Kahri J; Porthan K; Matikainen N; Soderlund S; Pietilainen K; Hakkarainen A; Lundbom N; Nilsson R; Stahlman M; Adiels M; Parini P; Packard C; Boren J
Article: JOURNAL OF INTERNAL MEDICINE. 2019;286(6):660-675

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy

Saliba-Gustafsson P; Pedrelli M; Gertow K; Werngren O; Janas V; Pourteymour S; Baldassarre D; Tremoli E; Veglia F; Rauramaa R; Smit AJ; Giral P; Kurl S; Pirro M; de Faire U; Humphries SE; Hamsten A; Goncalves I; Orho-Melander M; Franco-Cereceda A; Boren J; Eriksson P; Magne J; Parini P; Ehrenborg E; Sirtori CR; Castelnuovo S; Amato M; Frigerio B; Ravani A; Sansaro D; Tedesco C; Bovis F; Discacciati A; Ahl M; Blomgren G; Eriksson MJ; Fahlstadius P; Heinonen M; Nilson L; Cooper J; Acharya J; Huttunen K; Rauramaa E; Pekkarinen H; Penttila IM; Torronen J; van Gessel AI; van Roon AM; Teune GC; Kuipers WD; Bruin M; Nicolai A; Haarsma-Jorritsma P; Mulder DJ; Bilo HJG; Smeets GH; Beaudeux JL; Kahn JF; Carreau V; Kontush A; Karppi J; Nurmi T; Nyyssonen K; Salonen R; Tuomainen TP; Tuomainen J; Kauhanen J; Vaudo G; Alaeddin A; Siepi D; Lupattelli G; Schillaci G
Article: DIGESTIVE AND LIVER DISEASE. 2019;51(7):1016-1022

Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice

Ahmed O; Pramfalk C; Pedrelli M; Olin M; Steffensen KR; Eriksson M; Parini P
Article: NATURE COMMUNICATIONS. 2019;10(1):1684

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα

Liang N; Damdimopoulos A; Goni S; Huang Z; Vedin L-L; Jakobsson T; Giudici M; Ahmed O; Pedrelli M; Barilla S; Alzaid F; Mendoza A; Schroder T; Kuiper R; Parini P; Hollenberg A; Lefebvre P; Francque S; Van Gaal L; Staels B; Venteclef N; Treuter E; Fan R
Article: BIOLOGY OF SEX DIFFERENCES. 2019;10(1):11

Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse

Gonzalez-Granillo M; Helguero LA; Alves E; Archer A; Savva C; Pedrelli M; Ahmed O; Li X; Domingues MR; Parini P; Gustafsson J-A; Korach-Andre M
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2019;479:147-158

ERβ activation in obesity improves whole body metabolism via adipose tissue function and enhanced mitochondria biogenesis

Gonzalez-Granillo M; Savva C; Li X; Fitch M; Pedrelli M; Hellerstein M; Parini P; Korach-Andre M; Gustafsson J-A
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2018;7(24):e009876

Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Ahmed O; Littmann K; Gustafsson U; Pramfalk C; Oorni K; Larsson L; Minniti ME; Sahlin S; Camejo G; Parini P; Eriksson M
Article: ATHEROSCLEROSIS. 2018;275:246-255

Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption

Parini P; Melhuish TA; Wotton D; Larsson L; Ahmed O; Eriksson M; Pramfalk C
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2018;38(8):1723-1737

STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia

Cansby E; Magnusson E; Nunez-Duran E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Stahlman M; Howell BW; Marschall H-U; Boren J; Mahlapuu M
Article: DRUGS. 2017;77(15):1613-1621

Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia

Jakobsson T; Vedin L-L; Parini P
Article: JOURNAL OF LIPID RESEARCH. 2017;58(2):420-432

The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis

Ferguson D; Zhang J; Davis MA; Helsley RN; Vedin L-L; Lee RG; Crooke RM; Graham MJ; Allende DS; Parini P; Brown JM
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(2):137-148

Does statins promote vascular calcification in chronic kidney disease?

Chen Z; Qureshi AR; Parini P; Hurt-Camejo E; Ripsweden J; Brismar TB; Barany P; Jaminon AM; Schurgers LJ; Heimburger O; Lindholm B; Stenvinkel P
Article: SCIENTIFIC REPORTS. 2016;6:36937

Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction

Duszka K; Picard A; Ellero-Simatos S; Chen J; Defernez M; Paramalingam E; Pigram A; Vanoaica L; Canlet C; Parini P; Narbad A; Guillou H; Thorens B; Wahli W
Article: JOURNAL OF CONTROLLED RELEASE. 2016;241:57-67

Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum-infected red blood cells

Moles E; Moll K; Ch'ng J-H; Parini P; Wahlgren M; Fernandez-Busquets X
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2016;118(6):499-502

Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations

Bjorkhem-Bergman L; Nylen H; Eriksson M; Parini P; Diczfalusy U
Article: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. 2016;310(11):g952-g961

Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo

Li M; Ellis E; Johansson H; Nowak G; Isaksson B; Gnocchi D; Parini P; Axelsson J
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2016;36(5):787-791

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report

Apro J; Tietge UJF; Dikkers A; Parini P; Angelin B; Rudling M
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2016;1861(1):51-59

Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism

Pramfalk C; Larsson L; Hardfeldt J; Eriksson M; Parini P
Article: JOURNAL OF LIPID RESEARCH. 2015;56(8):1633-1639

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients

Apro J; Parini P; Broijersen A; Angelin B; Rudling M
Article: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. 2015;82:186-193

RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form

Rocha CSJ; Wiklander OPB; Larsson L; Moreno PMD; Parini P; Lundin KE; Smith CIE
Article: CELL REPORTS. 2015;10(3):326-338

The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance

Warrier M; Shih DM; Burrows AC; Ferguson D; Gromovsky AD; Brown AL; Marshall S; McDaniel A; Schugar RC; Wang Z; Sacks J; Rong X; Vallim TDA; Chou J; Ivanova PT; Myers DS; Brown HA; Lee RG; Crooke RM; Graham MJ; Liu X; Parini P; Tontonoz P; Lusis AJ; Hazen SL; Temel RE; Brown JM
Article: HEPATOLOGY. 2015;61(1):161-170

Prevention of Spontaneous Hepatocarcinogenesis in Farnesoid X Receptor-Null Mice by Intestinal-Specific Farnesoid X Receptor Reactivation

Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Article: ATHEROSCLEROSIS. 2014;237(2):544-554

The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice

Kannisto K; Rehnmark S; Slatis K; Webb P; Larsson L; Gafvels M; Eggertsen G; Parini P
Article: HEPATOLOGY. 2014;59(5):1791-1802

Estrogen Receptor Ligands Ameliorate Fatty Liver Through a Nonclassical Estrogen Receptor/Liver X Receptor Pathway in Mice

Han S-I; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin L-L; Kishimoto H; Shimano H; Gustafsson J-A; Yanagisawa J
Article: JOURNAL OF LIPID RESEARCH. 2014;55(4):709-717

TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2

Pramfalk C; Melhuish TA; Wotton D; Jiang Z-Y; Eriksson M; Parini P
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2014;306(5):E494-E502

Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis

Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson J-A; Korach-Andre M
Article: PLOS ONE. 2014;9(4):e93552

Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice

Pedrelli M; Davoodpour P; Degirolamo C; Gomaraschi M; Graham M; Ossoli A; Larsson L; Calabresi L; Gustafsson J-A; Steffensen KR; Eriksson M; Parini P
Article: PLOS ONE. 2014;9(11):e113619

Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor

Wuolikainen A; Acimovic J; Loevgren-Sandblom A; Parini P; Andersen PM; Bjoerkhem I
Article: DRUG METABOLISM AND DISPOSITION. 2013;41(9):1610-1615

Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver

Bjorkhem-Bergman L; Bergstrom H; Johansson M; Parini P; Eriksson M; Rane A; Ekstrom L
Article: PLOS ONE. 2013;8(12):e78534

The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient Mice

Mork L-M; Rehnmark S; Davoodpour P; Norata GD; Larsson L; Witt M-R; Malm J; Parini P
Article: PLOS ONE. 2013;8(11):e78550

Mice with Chimeric Livers Are an Improved Model for Human Lipoprotein Metabolism

Ellis ECS; Nauglers S; Parini P; Mork L-M; Jorns C; Zemack H; Sandblom AL; Bjorkhem I; Ericzon B-G; Wilson EM; Strom SC; Grompe M
Article: PLOS ONE. 2013;8(7):e68534

Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?

Maioli S; Bavner A; Ali Z; Heverin M; Ismail M-A; Puerta E; Olin M; Saeed A; Shafaati M; Parini P; Cedazo-Minguez A; Bjorkhem I
Article: MOLECULAR ENDOCRINOLOGY. 2012;26(12):1980-1990

Fasting-Induced FGF21 Is Repressed by LXR Activation via Recruitment of an HDAC3 Corepressor Complex in Mice

Archer A; Venteclef N; Mode A; Pedrelli M; Gabbi C; Clement K; Parini P; Gustafsson J-A; Korach-Andre M
Article: JOURNAL OF INTERNAL MEDICINE. 2012;272(5):452-464

LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile

Hu X; Steffensen KR; Jiang Z-Y; Parini P; Gustafsson J-A; Gafvels M; Eggertsen G
Article: FASEB JOURNAL. 2012;26(8):3282-3291

SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice

Zadjali F; Santana-Farre R; Vesterlund M; Carow B; Mirecki-Garrido M; Hernandez-Hernandez I; Flodstrom-Tullberg M; Parini P; Rottenberg M; Norstedt G; Fernandez-Perez L; Flores-Morales A
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2012;30(2):202-207

Physical training increases osteoprotegerin in postmenopausal women

Bergstrom I; Parini P; Gustafsson SA; Andersson G; Brinck J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2012;417(3):1046-1051

Statins inhibit expression of Thioredoxin reductase 1 in rat and human liver and reduce tumour development

Skogastierna C; Johansson M; Parini P; Eriksson M; Eriksson LC; Ekstrom L; Bjorkhem-Bergman L
Article: PLOS ONE. 2012;7(11):e48694

Increased Expression of the Very Low-Density Lipoprotein Receptor Mediates Lipid Accumulation in Clear-Cell Renal Cell Carcinoma

Sundelin JP; Stahlman M; Lundqvist A; Levin M; Parini P; Johansson ME; Boren J
Article: PLOS ONE. 2012;7(5):e37386

Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood

Santana-Farre R; Mirecki-Garrido M; Bocos C; Henriquez-Hernandez LA; Kahlon N; Herrera E; Norstedt G; Parini P; Flores-Morales A; Fernandez-Perez L
Article: JOURNAL OF INTERNAL MEDICINE. 2011;270(4):377-387

Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo

Shafaati M; Olin M; Bavner A; Pettersson H; Rozell B; Meaney S; Parini P; Bjorkhem I
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2011;301(1):E210-E222

Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice

Korach-Andre M; Archer A; Gabbi C; Barros RP; Pedrelli M; Steffensen KR; Pettersson AT; Laurencikiene J; Parini P; Gustafsson J-A
Article: HEART SURGERY FORUM. 2011;14(3):E195-E197

Late Cardiac Tamponade by Chylous Pericardial Effusion after Coronary Artery Bypass Surgery: Case Report

Albage A; Eggertsen G; Parini P
Article: JOURNAL OF INTERNAL MEDICINE. 2011;269(3):333-339

Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism

Pramfalk C; Parini P; Gustafsson U; Sahlin S; Eriksson M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(1):403-408

Both liver-X receptor (LXR) isoforms control energy expenditure by regulating Brown Adipose Tissue activity

Korach-Andre M; Archer A; Barros RP; Parini P; Gustafsson J-A
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(1):184-190

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease

Carrero JJ; Qureshi AR; Nakashima A; Arver S; Parini P; Lindholm B; Barany P; Heimbuerger O; Stenvinkel P
Article: WORLD JOURNAL OF GASTROENTEROLOGY. 2010;16(47):5958-5964

Thyroid hormones and thyroid hormone receptors: Effects of thyromimetics on reverse cholesterol transport

Pedrelli M; Pramfalk C; Parini P
Article: JOURNAL OF LIPID RESEARCH. 2010;51(11):3289-3298

Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice

Slatis K; Gafvels M; Kannisto K; Ovchinnikova O; Paulsson-Berne G; Parini P; Jiang Z-Y; Eggertsen G
Article: PLOS ONE. 2010;5(9):e13087

Decreased Fat Storage by Lactobacillus Paracasei Is Associated with Increased Levels of Angiopoietin-Like 4 Protein (ANGPTL4)

Aronsson L; Huang Y; Parini P; Korach-Andre M; Hakansson J; Gustafsson J-A; Pettersson S; Arulampalam V; Rafter J
Article: CELL METABOLISM. 2010;12(2):187-193

Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis

Lo Sasso G; Murzilli S; Salvatore L; D'Ernco I; Petruzzelli M; Conca P; Jiang Z-Y; Calabresi L; Parini P; Moschetta A
Article: JOURNAL OF LIPID RESEARCH. 2010;51(6):1354-1362

HNF1α and SREBP2 are important regulators of NPC1L1 in human liver

Pramfalk C; Jiang Z-Y; Cai Q; Hu H; Zhang S-D; Han T-Q; Eriksson M; Parini P
Article: HEPATOLOGY. 2010;51(4):1334-1344

Down-Regulation of the LXR Transcriptome Provides the Requisite Cholesterol Levels to Proliferating Hepatocytes

Lo Sasso G; Celli N; Caboni M; Murzilli S; Salvatore L; Morgano A; Vacca M; Pagliani T; Parini P; Moschetta A
Article: ANTICANCER RESEARCH. 2010;30(4):1105-1112

Lovastatin Prevents Carcinogenesis in a Rat Model for Liver Cancer. Effects of Ubiquinone Supplementation

Bjorkhem-Bergman L; Acimovic J; Torndal U-B; Parini P; Eriksson LC
Article: GENES & DEVELOPMENT. 2010;24(4):381-395

GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRβ in the hepatic acute phase response

Venteclef N; Jakobsson T; Ehrlund A; Damdimopoulos A; Mikkonen L; Ellis E; Nilsson L-M; Parini P; Janne OA; Gustafsson J-A; Steffensen KR; Treuter E
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2010;298(2):E167-E178

Separate and overlapping metabolic functions of LXRα and LXRβ in C57Bl/6 female mice

Korach-Andre M; Parini P; Larsson L; Arner A; Steffensen KR; Gustafsson J-A
Article: ATHEROSCLEROSIS. 2009;207(1):266-271

ACAT2 and human hepatic cholesterol metabolism: Identification of important gender-related differences in normolipidemic, non-obese Chinese patients

Parini P; Jiang Z-Y; Einarsson C; Eggertsen G; Zhang S-D; Rudel LL; Han T-Q; Eriksson M
Article: LIPIDS. 2009;44(11):1011-1027

Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats

Gustavsson C; Parini P; Ostojic J; Cheung L; Hu J; Zadjali F; Tahir F; Brismar K; Norstedt G; Tollet-Egnell P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2009;29(8):1235-1241

Control of ACAT2 Liver Expression by HNF4α Lesson From MODY1 Patients

Pramfalk C; Karlsson E; Groop L; Rudel LL; Angelin B; Eriksson M; Parini P
Article: ATHEROSCLEROSIS. 2009;204(2):381-387

Hypercholesterolemia leads to elevated TGF-β1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice

Zhou X; Johnston TP; Johansson D; Parini P; Funa K; Svensson J; Hansson GK
Article: CIRCULATION RESEARCH. 2009;104(8):961-968

T Cell-Mediated Inflammation in Adipose Tissue Does Not Cause Insulin Resistance in Hyperlipidemic Mice

Sultan A; Strodthoff D; Robertson A-K; Paulsson-Berne G; Fauconnier J; Parini P; Ryden M; Thierry-Mieg N; Johansson ME; Chibalin AV; Zierath JR; Arner P; Hansson GK
Article: CARCINOGENESIS. 2009;30(4):575-579

The oxysterol receptor LXR inhibits proliferation of human breast cancer cells

Vedin L-L; Lewandowski SA; Parini P; Gustafsson J-A; Steffensen KR
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;20(3):613-620

Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients

Carrero JJ; Qureshi AR; Parini P; Arver S; Lindholm B; Barany P; Heimburger O; Stenvinkel P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009;379(1):49-54

Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients

Jiang Z-Y; Jiang C-Y; Wang L; Wang J-C; Zhang S-D; Einarsson C; Eriksson M; Han T-Q; Parini P; Eggertsen G
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2008;28(6):1200-1206

Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2

Parini P; Gustafsson U; Davis MA; Larsson L; Einarsson C; Wilson M; Rudling M; Tomoda H; Omura S; Sahlin S; Angelin B; Rudel LL; Eriksson M
Article: PLOS ONE. 2008;3(3):e1713

Monomeric Tartrate Resistant Acid Phosphatase Induces Insulin Sensitive Obesity

Lang P; van Harmelen V; Ryden M; Kaaman M; Parini P; Carneheim C; Cassady AI; Hume DA; Andersson G; Arner P
Article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2008;471(1):63-71

Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in mice

Leikin-Frenkel A; Parini P; Konikoff FM; Benthin L; Lelkin-Gobbi D; Goldiner I; Einarsson C; Gilat T
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(6):2094-2099

Liver X receptor β (LXRβ):: A link between β-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia

Kim H-J; Fan X; Gabbi C; Yakimchuk K; Parini P; Warner M; Gustafsson J-A
Article: JOURNAL OF LIPID RESEARCH. 2008;49(2):464-472

Increased expression of LXRα, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients

Jiang Z-Y; Parini P; Eggertsen G; Davis MA; Hu H; Suo G-J; Zhang S-D; Rudel LL; Han T-Q; Einarsson C
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;364(2):402-409

Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells

Pramfalk C; Angelin B; Eriksson M; Parini P
Article: CLINICAL LIPIDOLOGY. 2007;2(6):603-607

Targeting liver X receptor β:: a new therapeutic approach to prevent atherosclerosis?

Parini P; Gustafsson J-A
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2007;27(10):2191-2197

Studies on the cholesterol-free mouse -: Strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol

Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Loevgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Bjoerkhem I
Article: MOLECULAR PHARMACOLOGY. 2007;72(4):947-955

Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2diphenylethyl)amino]propyloxy] phenylacetic acid hydrochloride (GW3965)

Kotokorpi P; Ellis E; Parini P; Nilsson L-M; Strom S; Steffensen KR; Gustafsson J-A; Mode A
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;293(3):E737-E742

Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol

Gaelman C; Matasconi M; Persson L; Parini P; Angelin B; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;357(3):707-711

Bile acids and lipoprotein metabolism: Effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression

Nilsson L-M; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;348(1):176-182

Improved metabolic control by depletion of Liver X Receptors in mice

Schuster GU; Johansson L; Kietz S; Stulnig TM; Parini P; Gustafsson J-A
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2006;36(2):98-104

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system

Parini P; Johansson L; Bröijersén A; Angelin B; Rudling M
Article: JOURNAL OF LIPID RESEARCH. 2006;47(2):421-430

Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice

Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2005;1736(3):221-227

Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: Effects of hypophysectomy and growth hormone treatment

Matasconi M; Panini P; Angelin B; Rudling M
Article: JOURNAL OF LIPID RESEARCH. 2005;46(9):1868-1876

Control of ACAT2 liver expression by HNF1

Pramfalk C; Davis MA; Eriksson M; Rudel LL; Parini P
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2005;1735(3):167-175

Cholic acid as key regulator of cholesterol synthesis, intestinal absorption and hepatic storage in mice

Murphy C; Parini P; Wang J; Björkhem I; Eggertsen G; Gåfvels M
Article: JOURNAL OF LIPID RESEARCH. 2005;46(8):1633-1642

LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver

Gnerre C; Schuster GU; Roth A; Handschin C; Johansson L; Looser R; Parini P; Podvinec M; Robertsson K; Gustafsson J; Meyer UA
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005;102(29):10297-10302

Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice

Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2005;25(6):1112-1118

ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia

Rudel LL; Lee RG; Parini P
Article: CIRCULATION RESEARCH. 2005;96(4):427-434

Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis

Zhou XH; Robertson AKL; Rudling M; Parini P; Hansson GK
Article: CIRCULATION. 2004;110(14):2017-2023

ACAT2 is localized to Hepatocytes and is the major cholesterol-esterifying enzyme in human liver

Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
Article: CIRCULATION RESEARCH. 2004;94(12):1579-1588

Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice

Bråkenhielm E; Cao RH; Gao BH; Angelin B; Cannon B; Parini P; Cao YH
Article: PHYSIOLOGICAL GENOMICS. 2004;16(2):261-267

Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles

Tollet-Egnell P; Parini P; Ståhlberg N; Lönnstedt I; Lee NH; Rudling M; Flores-Morales A; Norstedt G
Article: ATHEROSCLEROSIS SUPPLEMENTS. 2002;3(4):23-30

Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL

Angelin B; Parini P; Eriksson M
Article: CIRCULATION. 2002;106(9):1147-1153

Accumulation of foam cells in liver X receptor-deficient mice

Schuster GU; Parini P; Wang L; Alberti S; Steffensen KR; Hansson GK; Angelin B; Gustafsson J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2002;293(5):1333-1340

Different regulation of the LXRα promoter activity by isoforms of CCAAT/enhancer-binding proteins

Steffensen KR; Schuster GU; Parini P; Holter E; Sadek CM; Cassel T; Eskild W; Gustafsson J
Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2001;78(1):83-88

Estrogenic influence on the regulation of hepatic estrogen receptor-α and serum level of angiotensinogen in female rats

Stavréus-Evers A; Parini P; Freyschuss B; Elger W; Reddersen G; Sahlin L; Eriksson H
Article: JOURNAL OF CLINICAL INVESTIGATION. 2001;107(5):565-573

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

Alberti S; Schuster G; Parini P; Feltkamp D; Diczfalusy U; Rudling M; Angelin B; Björkhem I; Pettersson S; Gustafsson J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;278(3):640-645

Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice

Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson J
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2000;20(7):1817-1823

Biphasic effects of the natural estrogen 17β-estradiol on hepatic cholesterol metabolism in intact female rats

Parini P; Angelin B; Stavréus-Evers A; Freyschuss B; Eriksson H; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1999;19(4):832-839

Cholesterol and lipoprotein metabolism in aging - Reversal of hypercholesterolemia by growth hormone treatment in old rats

Parini P; Angelin B; Rudling M
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935

Lipoprotein receptors in acute myelogenous leukemia -: Failure to defect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation

Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(9):1800-1805

Importance of estrogen receptors in hepatic LDL receptor regulation

Parini P; Angelin B; Rudling M
Article: JOURNAL OF CLINICAL INVESTIGATION. 1997;99(9):2239-2245

Growth hormone and bile acid synthesis - Key role for the activity of hepatic microsomal cholesterol 7 alpha-hydroxylase in the rat

Rudling M; Parini P; Angelin B
Article: ENDOCRINOLOGY. 1995;136(9):3767-3773

GROWTH-HORMONE SPECIFICALLY STIMULATES THE EXPRESSION OF LOW-DENSITY-LIPOPROTEIN RECEPTORS IN HUMAN HEPATOMA-CELLS

PARINI P; ANGELIN B; LOBIE PE; NORSTEDT G; RUDLING M
Visa fler

Alla övriga publikationer

Editorial comment: ATHEROSCLEROSIS. 2024;397:118562

HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion?

Parini P
Review: AGEING RESEARCH REVIEWS. 2024;94:102194

Lipid droplets, autophagy, and ageing: A cell-specific tale

Maestri A; Garagnani P; Pedrelli M; Hagberg CE; Parini P; Ehrenborg E
Review: PROGRESS IN CARDIOVASCULAR DISEASES. 2023;79:2-11

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Banach M; Penson PE; Farnier M; Fras Z; Latkovskis G; Laufs U; Paneni F; Parini P; Pirro M; Reiner Z; Vrablik M; Escobar C
Review: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 2021;50(6):401-411

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgozoglu L
Editorial comment: ATHEROSCLEROSIS. 2021;322:77-81

Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in Europe

Parini P; Frikke-Schmidt R; Tselepis AD; Moulin P; von Eckardstein A; Binder CJ; Catapano AL; Ray KK; Tokgozoglu L
Review: CLINICAL EPIGENETICS. 2021;13(1):66

Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside

Sarno F; Benincasa G; List M; Barabasi A-L; Baumbach J; Ciardiello F; Filetti S; Glass K; Loscalzo J; Marchese C; Maron BA; Paci P; Parini P; Petrillo E; Silverman EK; Verrienti A; Altucci L; Napoli C
Editorial comment: AMERICAN JOURNAL OF MEDICINE. 2020;133(9):e451-e454

The Network Medicine Imperative and the Need for an International Network Medicine Consortium

Parini P; Altucci L; Balligand J-L; Baumbach J; Ferdinandy P; Filetti S; Maron BA; Petrillo E; Silverman EK; Barabasi A-L; Loscalzo J
Editorial comment: NPJ SYSTEMS BIOLOGY AND APPLICATIONS. 2020;6(1):29

A global network for network medicine

Maron BA; Altucci L; Balligand J-L; Baumbach J; Ferdinandy P; Filetti S; Parini P; Petrillo E; Silverman EK; Barabasi A-L; Loscalzo J
Review: NATURE REVIEWS ENDOCRINOLOGY. 2018;14(10):576-590

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Franceschi C; Garagnani P; Parini P; Giuliani C; Santoro A
Editorial comment: JOURNAL OF LIPID RESEARCH. 2018;59(9):1551-1553

Hepatic thyroid hormone receptor β1 agonism: good for lipids, good for bile?

Dawson PA; Parini P
Review: JOURNAL OF INTERNAL MEDICINE. 2017;281(6):534-553

Can LDL cholesterol be too low? Possible risks of extremely low levels

Olsson AG; Angelin B; Assmann G; Binder CJ; Bjoerkhem I; Cedazo-Minguez A; Cohen J; von Eckardstein A; Farinaro E; Mueller-Wieland D; Parhofer KG; Parini P; Rosenson RS; Starup-Linde J; Tikkanen MJ; Yvan-Charvet L
Review: ACTA PHYSIOLOGICA. 2016;217(3):184-216

Emerging role of thyroid hormone metabolites

Gnocchi D; Steffensen KR; Bruscalupi G; Parini P
Review: BIOLOGY-BASEL. 2015;4(1):104-132

Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism.

Gnocchi D; Pedrelli M; Hurt-Camejo E; Parini P
Published conference paper: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2015;1851(1):9-12

Role of TG-interacting factor (Tgif) in lipid metabolism

Pramfalk C; Eriksson M; Parini P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2013;45(5):1780-1786

Serum Apolipoprotein E as a Marker to Monitor Graft Function After Hepatocyte Transplantation in a Clinically Relevant Mouse Model

Jorns C; Takahashi T; Callaghan E; Zemack H; Larsson L; Nowak G; Parini P; Ericzon B-G; Ellis E
Review: EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY. 2012;114(6):624-633

Cholesteryl esters and ACAT

Pramfalk C; Eriksson M; Parini P
Review: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2011;1812(8):929-937

Role of thyroid receptor β in lipid metabolism

Pramfalk C; Pedrelli M; Parini P
Review: CURRENT OPINION IN LIPIDOLOGY. 2011;22(3):225-230

Hepatic Niemann-Pick C1-like 1

Pramfalk C; Jiang Z-Y; Parini P
Editorial comment: ATHEROSCLEROSIS. 2011;215(1):249-255

Report of the 33rd Annual Conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010

Bernini F; Fisher R; Freeman D; Groen A; Kalopissis A; Malle E; Mulder M; Niemeier A; Parini P; Hansen AT; von Eckardstein A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2010;11(2):64

EFFECTS OF HIGH DOSE STATIN ON THE HUMAN HEPATIC EXPRESSION OF GENES INVOLVED IN CARBOHYDRATE AND TRIGLYCERIDE METABOLISM

Pramfalk C; Parini P; Gustafsson U; Sahlin S; Eriksson M
Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2009;302(3):255

Carotid Atherosclerosis Progression and ACAT Inhibition

Parini P; Eriksson M; Rudel LL
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):24

ACAT2 and human hepatic cholesterol mkiabolism: Identification of important gender-related differences

Jiang ZY; Parini P; Einarsson C; Eggertsen G; Davis MA; Wang L; Zhang SD; Rudel LL; Han TQ; Ericsson M
Corrigendum: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;348(1):326

Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice (vol 278, pg 640, 2000)

Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly-Y M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson J-A
Editorial comment: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2003;23(3):374-375

Is there a need for cholesteryl ester transfer protein inhibition?

Parini P; Rudel LL
Published conference paper: GROWTH HORMONE & IGF RESEARCH. 1999;9:1-7

Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans

Rudling M; Parini P; Angelin B
Visa fler

Anställningar

Professor/Överläkare, Medicin, Huddinge, Karolinska Institutet, 2015-
Professor/Överläkare, Laboratoriemedicin, Karolinska Institutet, 2012-

Examina och utbildning

Docent, Gastroenterologi, Karolinska Institutet, 2007
MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Huddinge, Karolinska Institutet, 1999

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI